Metagenomics and antibiotics

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Thirty-day mortality of nosocomial systemic bacterial infections according to antibiotic susceptibility in an 800-bed teaching hospital in France  D.
P. Gautret, E. Botelho-Nevers, P. Brouqui, P. Parola 
New epidemiology of Staphylococcus aureus infection in Asia
Benchmarking inappropriate empirical antibiotic treatment
G. Cornaglia, A. Lönnroth, M. Struelens 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Changes in the intestinal microbiota from adulthood through to old age
Herpes zoster in non-hospitalized children
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
P. Davey, C. Pagliari, A. Hayes  Clinical Microbiology and Infection 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
Molecular mechanism of gentamicin resistance in Bartonella henselae
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
A. Fajardo, J.F. Linares, J.L. Martínez 
G. Höffken  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H
Clinical Microbiology and Infection
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Clinical infection services—the Leiden experience
An after-hours clinical liaison blood culture service—is it worth it?
C. Wongsrichanalai, C.H. Sibley  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
Clinical Microbiology and Infection
W. Eugene Sanders, Christine C. Sanders 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Metagenomics of human microbiome: beyond 16s rDNA
B.A. Cunha  Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
Community-acquired acute bacterial meningitis in the elderly in Turkey
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis  Bernard Grenier  Clinical.
Localized Mycobacterium avium complex infection in a patient on HAART
The future of diagnostic bacteriology
Presentation transcript:

Metagenomics and antibiotics L. Garmendia, A. Hernandez, M.B. Sanchez, J.L. Martinez  Clinical Microbiology and Infection  Volume 18, Pages 27-31 (July 2012) DOI: 10.1111/j.1469-0691.2012.03868.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Number of papers on antibiotics and metagenomics that can be found on PubMed. The figure shows the distribution along time of papers recorded in PubMed using the query [(metagenomic*) AND (antibiotic* OR antimicrobial*)]. The search was made on 17 October 2011. Clinical Microbiology and Infection 2012 18, 27-31DOI: (10.1111/j.1469-0691.2012.03868.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Second-order selection of resistant clones or elements harbouring antibiotic resistance. The acquisition of resistance by a member of a complex microbiota has consequences for the structure of such microbiota that will depend on the presence of an antibiotic. In the absence of antibiotic selective pressure, if the microbiota contains intrinsically resistant microorganisms (black ovals) or one of the members acquires a resistance determinant (star inside ovals), the intrinsically resistant clone will be maintained at the same rate and the acquired resistance gene will probably be lost if it confers a fitness cost (b). In these circumstances it is expected that the homeostasis of the system is maintained (c). However, if the microbiota is submitted to antibiotic selective pressure (d), intrinsically resistant clones will expand at the expense of the susceptible ones that are killed by the antibiotics. In a similar way, those microorganisms acquiring the resistance element will survive allowing the expansion of the specific clones harbouring the resistance determinant. Finally, the transfer of the resistance element will allow the survival of other bacterial clones/species in the presence of the antibiotic. As the consequence, the successful spread of this element will be increased by a second-order selection process. Clinical Microbiology and Infection 2012 18, 27-31DOI: (10.1111/j.1469-0691.2012.03868.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions